Affiliation:
1. From the Department of Anesthesiology (G.L., V.M., J.H.W.) and the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Magee–Womens Research Institute and Foundation (F.L.F.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; and the Department of Medicine and Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, Pennsyl
Abstract
Abstract
Background
Cost-effectiveness analyses on cell salvage for cesarean delivery to inform national and societal guidelines on obstetric blood management are lacking. This study examined the cost-effectiveness of cell salvage strategies in obstetric hemorrhage from a societal perspective.
Methods
Markov decision analysis modeling compared the cost-effectiveness of three strategies: use of cell salvage for every cesarean delivery, cell salvage use for high-risk cases, and no cell salvage. A societal perspective and lifetime horizon was assumed for the base case of a 26-yr-old primiparous woman presenting for cesarean delivery. Each strategy integrated probabilities of hemorrhage, hysterectomy, transfusion reactions, emergency procedures, and cell salvage utilization; utilities for quality of life; and costs at the societal level. One-way and Monte Carlo probabilistic sensitivity analyses were performed. A threshold of $100,000 per quality-adjusted life-year gained was used as a cost-effectiveness criterion.
Results
Cell salvage use for cases at high risk for hemorrhage was cost-effective (incremental cost-effectiveness ratio, $34,881 per quality-adjusted life-year gained). Routine cell salvage use for all cesarean deliveries was not cost-effective, costing $415,488 per quality-adjusted life-year gained. Results were not sensitive to individual variation of other model parameters. The probabilistic sensitivity analysis showed that at the $100,000 per quality-adjusted life-year gained threshold, there is more than 85% likelihood that cell salvage use for cases at high risk for hemorrhage is favorable.
Conclusions
The use of cell salvage for cases at high risk for obstetric hemorrhage is economically reasonable; routine cell salvage use for all cesarean deliveries is not. These findings can inform the development of public policies such as guidelines on management of obstetric hemorrhage.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Anesthesiology and Pain Medicine
Reference54 articles.
1. The World Health Organization Fact Sheet No. 348: Maternal Mortality. Available at: http://www.who.int/mediacentre/factsheets/fs348/en/. Accessed November 26, 2015
2. Cell salvage in obstetrics.;Anesth Analg,2015
3. Indications and contraindications of cell salvage.;Transfusion,2004
4. Cell salvage in obstetrics.;Int J Obstet Anesth,2008
5. Cell salvage as part of a blood conservation strategy in anaesthesia.;Br J Anaesth,2010
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献